H Adamski

Publications (37)36.58 Total impact

• Article: [Febrile maculopapular eruption due to dronedarone].

  J Miquel, H Adamski, E Oger, E Pollard, F Le Gall, J Chevrant-Breton, A Dupuy
  Annales de Dermatologie et de Vénéréologie 11/2012; 139(11):740-2. · 0.72 Impact Factor
• Article: [Eruptive naevi in epidermolysis bullosa hereditaria patients].

  J Miquel, J Chevrant-Breton, A Dupuy, F Le Gall, E Bourdon-Lannoy, H Adamski, C Bodemer
  [show abstract] [hide abstract]
  ABSTRACT: EB naevus (EBN) are little-known, atypical, eruptive, pigmented melanocytic lesions that may occur in former sites of bullae occurring in epidermolysis bullosa hereditaria (EBH). We sought to describe the characteristics of such lesions and assess their course. This was a retrospective, two-centre study in which data was collated from the medical files of patients with EBN. We analyzed the patients' demographical data as well as the clinical, dermatoscopic, pathological features of EBN and their progression. Eight patients were studied: they were principally Caucasian (5/8), with a sex ratio of 1. All variants of EBH were represented and most were recessive (63%). We analysed 22 EBN, all atypical and emerging before the age of 10 years (73%), ubiquitously distributed and measuring greater than 5 cm(2) (25%). Of the 13 EBN subjected to dermatoscopy, 12 exhibited a benign reticular pattern. Four were biopsied, and analysis revealed three common naevi and one lentigo. After a median follow-up of 8 years, the EBN seen were either stable (68%), had regressed (23%) or had disappeared (one case). No cases of melanoma were diagnosed. EBN are acquired and atypical pigmented naevi. Sixty-four cases of EBN have been reported in the literature up to date. The dermatoscopic features may be evocative of melanoma (17/23 EBN), but to our knowledge no cases of melanoma at a naevus site have been reported. Recessive transmission of EBH appears to be a risk factor (63% of cases), a finding supported by certain pathophysiological hypotheses. EBN present atypical clinical and dermatoscopic features. However, while prophylactic total excision did not appear warranted in the absence of any reported cases of melanoma, regular clinical follow-up is recommended.
  Annales de Dermatologie et de Vénéréologie 06/2012; 139(6-7):435-43. · 0.72 Impact Factor
• Article: [Strontium ranelate-induced DRESS syndrome].

  M Le Merlouette, H Adamski, M Dinulescu, F Le Gall, F Colin, H Grimaud, J Chevrant-Breton
  [show abstract] [hide abstract]
  ABSTRACT: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe form of adverse drug reaction. Strontium ranelate has recently been authorised for postmenopausal osteoporosis. We report a case of strontium ranelate-induced DRESS complicated by linear Ig A dermatosis due to vancomycin. A 77-year-old woman with osteoporosis had been treated by strontium ranelate for 4 weeks when she developed a febrile generalized skin rash. Blood tests showed eosinophilia (12.74 × 10(9)/L) and liver damage. A diagnosis of DRESS was made, leading to discontinuation of strontium ranelate and prescription of systemic corticosteroids. Two days later, methicillin-resistant Staphylococcus aureus bacteraemia occurred and treatment with vancomycin was started. The liver dysfunction resolved. After two weeks of antibiotherapy, bullous lesions were noted on the thighs. Skin biopsy results suggested a diagnosis of linear IgA bullous dermatosis. Vancomycin was stopped. Two weeks later, the eruption resolved. The eosinophil count gradually returned to normal after four months of corticosteroid therapy. More than 15 cases of DRESS syndrome have been reported in Europe, including 2 deaths related to ranelate strontium, prompting European health authorities to publish a warning concerning the risk of strontium ranelate-induced DRESS. A particular feature of our patient was complication with linear IgA bullous dermatosis caused by vancomycin. In conclusion, it is essential to be aware of the risk of severe cutaneous reaction to strontium ranelate, a new drug used to treat osteoporosis.
  Annales de Dermatologie et de Vénéréologie 02/2011; 138(2):124-8. · 0.72 Impact Factor
• Article: [Pemphigus vegetans: A rare form of pemphigus].

  M Rmili, H Adamski, L Lopez, F Le Gall, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 01/2011; 138(4):364-6. · 0.72 Impact Factor
• Article: [Tetanus as a complication of leg ulcer associated with necrotic purpura].

  L Lopez, H Adamski, Y Le Tulzo, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 12/2010; 137(12):820-2. · 0.72 Impact Factor
• Article: Physicians involved in the care of patients with high risk of skin cancer should be trained regarding sun protection measures: evidence from a cross sectional study.

  M Thomas, E Rioual, H Adamski, A-M Roguedas, L Misery, M Michel, F Chastel, J-L Schmutz, F Aubin, M-C Marguery, N Meyer
  [show abstract] [hide abstract]
  ABSTRACT: Knowledge, regarding sun protection, is essential to change behaviour and to reduce sun exposure of patients at risk for skin cancer. Patient education regarding appropriate or sun protection measures, is a priority to reduce skin cancer incidence. The aim of this study was to evaluate the knowledge about sun protection and the recommendations given in a population of non-dermatologists physicians involved in the care of patients at high risk of skin cancer. This study is a cross-sectional study. Physicians were e-mailed an anonymous questionnaire evaluating the knowledge about risk factors for skin cancer, sun protection and about the role of the physician in providing sun protection recommendations. Of the responders, 71.4% considered that the risk of skin cancer of their patients was increased when compared with the general population. All the responders knew that UV-radiations can contribute to induce skin cancers and 71.4% of them declared having adequate knowledge about sun protection measures. A proportion of 64.2% of them declared that they were able to give sun protection advices: using sunscreens (97.8%), wearing covering clothes (95.5%), performing regular medical skin examination (91.1%), to avoid direct sunlight exposure (77.8%), avoiding outdoor activities in the hottest midday hours (73.3%) and practising progressive exposure (44.4%). Non-dermatologist physicians reported a correct knowledge of UV-induced skin cancer risk factors. The majority of responders displayed adequate knowledge of sun protection measures and declared providing patients with sun protection recommendation on a regular basis. Several errors persisted.
  Journal of the European Academy of Dermatology and Venereology 04/2010; 25(1):19-23. · 2.98 Impact Factor
• Article: [A painful and exophytic hand lesion].

  C Chabbert, H Adamski, I Moustaghfir, S Minjolle-Cha, H Duval, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 12/2009; 136(12):912-4. · 0.72 Impact Factor
• Article: Melanoma-associated disseminated intravascular coagulation.

  C Lepelley-Dupont, N Meyer, T Lesimple, P Gueret, H Adamski, J Chevrant-Breton
  Journal of the European Academy of Dermatology and Venereology 07/2009; 23(6):720-1. · 2.98 Impact Factor
• Article: [Dermatological consultations at a French women's prison: analysis of a six-year period].

  H Adamski, R Chiron, F Paysant, A Taverson, B Bernard, D Veillard, J Chevrant-Breton, M Le Gueut-Develay
  Annales de Dermatologie et de Vénéréologie 11/2008; 135(10):682-3. · 0.72 Impact Factor
• Article: [Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept].

  I Lahbabi, H Adamski, S Le Jean, V Cannieux, E Polard, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 06/2008; 135(5):409-10. · 0.72 Impact Factor
• Article: [Pyoderma gangrenosum and aseptic pyosalpinx in a pregnant patient].

  M Dinulescu, P Vigy, C Droitcourt, H Adamski, N Rioux, J-F Bretagne, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 03/2007; 134(2):179-80. · 0.72 Impact Factor
• Article: [Chronic ulceration of the ear caused by Cryptococcus neoformans].

  H Adamski, S Pessel, V Ferraro, C Arvieux, S Chevrier, F Le Gall, J-P Gangneux, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 03/2007; 134(3 Pt 1):273-5. · 0.72 Impact Factor
• Article: [Efficacy of topical tacrolimus in Hailey-Hailey disease].

  V Ferraro, H Adamski, F Le Gall, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 06/2006; 133(5 Pt 1):475-6. · 0.72 Impact Factor
• Article: [Cervicofacial ulcerations caused by dental infection in children].

  M Loppin, H Adamski, M Larrègue, B Cadre, B Godey, J Chevrant-Breton
  [show abstract] [hide abstract]
  ABSTRACT: In children, chronic cervicofacial ulceration related to dental infection is rare. Thus the diagnosis is often late and the treatment is consequently delayed. We report 2 new cases. CASES REPORT: A 13-year-old boy presented with a 1-year history of chronic and suppurative ulceration on the right cheek. Culture was positive for actinomycetes. In spite of a prolonged and miscellaneous antibiotherapy, the lesion recured. The ulceration healed after the eradication of infection on a right superior molar. A 12-year-old girl presented with a right sub-mandibular ulceration, which appeared 3 months before. This lesion did not respond to penicillinotherapy given during 3 months. An infection on a right inferior molar was diagnosed on a tomodensitometry. 3 months after the tooth extraction, the ulceration healed without recurrence. CONCLUSION: These cases emphasize the interest to look for a dental infection at the origin of chronic cervicofacial lesion.
  Archives de Pédiatrie 03/2006; 13(2):149-51. · 0.30 Impact Factor
• Article: [The prospective multicenter study on standard photopatch tests by the French Society of Photodermatology from 1991-2001].

  F Leonard, H Adamski, A Bonnevalle, A Bottlaender, J-L Bourrain, C Goujon-Henry, D Leroy, J-R Manciet, M-C Marguery, J-L Peyron, P Plantin, H Roger, J-L Schmutz, G Terrier, M Vigan, P Bernard
  [show abstract] [hide abstract]
  ABSTRACT: To develop a standard panel of photopatch tests, the French Society of Photodermatology conducted a prospective study from 1991 to 2001 on the frequency of photoallergens encountered in France and on the relevance of the choice of the various photoallergens. Thirteen photobiology centers participated in the study from 1991 to 1995, and ten centers from 1995 to 2001. A set of 3 samples of photopatch tests was applied on any patient suspected of photoallergy. On Day 2, two sets were irradiated with ultraviolet A (UVA) and total spectrum (DEM 0.75); with the third set being used as control. Readings were made on D3 and D4. Two thousand sixty-seven patients were tested. Eight hundred fifty-six, i.e., 41% exhibited one or several positive tests. In the majority of cases it was a photoallergy (39.7 to 60% of cases) and eczema (29.5 to 45.6%). Photoaggravation was infrequent (7.9 to 10.3%). Cases of phototoxicity were rare. Sesquiterpenic lactones constantly provoked photoallergy, with 12 cases in 10 years. Although phenothiazines were the most photosensitizing allergens up until 1995, they were then overridden by ketoprofen in 1996 with 107 cases of UVA photosensitive reactions (75 cases) and total spectrum (32 cases). These were followed closely by sun screens, benzophenone (notably Eusolex 4360 with 54 pertinent cases of photoallergy) and dibenzoylmethane (with 31 cases due to Eusolex 8020). UVB filters were all potentially photosensitizing but to a lesser degree from 1 to 5 cases). Our results differ from those of Anglo-Saxon teams in the appearance of a new photoallergen, ketoprofen, which provoked numerous photosensitivities in both UVA and UVB. This justifies the systematic addition of this substance in our prospective set. Photoallergy was relatively rare, with around 100 cases reported within 10 years. Total spectrum irradiation of the photopatch tests revealed photoallergies that would not have been found with UVA alone. Study of photopatch tests has permitted the uniformization of the methodology in France, an overview of the frequency of the photoallergens tested and the development of a new standard set.
  Annales de Dermatologie et de Vénéréologie 05/2005; 132(4):313-20. · 0.72 Impact Factor
• Article: [Primary cutaneous cryptococcosis in transplant recipients: a report of two cases].

  C Droitcourt, H Adamski, C Arvieux, S Chevrier, F Le Gall, C Michelet, J Chevrant-Breton
  La Revue de Médecine Interne 03/2005; 26(2):157-9. · 0.61 Impact Factor
• Article: Positive photobiological investigation in reticular erythematous mucinosis syndrome.

  H Adamski, F Le Gall, J Chevrant-Breton
  [show abstract] [hide abstract]
  ABSTRACT: Reticular erythematous mucinosis (REM) syndrome is a rare disorder. Its clinical course is cyclic with remissions and exacerbations. In this disease, photosensitivity has previously been noticed but rarely demonstrated. We report three new cases with positive photobiological investigation. Three patients (two males, one female) with a mean age 47 years were seen with reticular erythematous papules on the upper chest and or back. After sun exposure, the lesions were exacerbated. Skin biopsies showed dermal lymphocytic perivascular infiltration with mucin deposition between collagen bundles. Direct immunofluorescence was negative. Antinuclear antibodies were absent. In cabin, ultraviolet (UV)A exposure reproduced clinically and histologically REM lesions in our cases. UVA and UVB provocating phototests were negative. In all patients treatment with oral antimalarials and external photoprotection was effective. In our patients, we confirm the photosensitive feature of REM syndrome by provocative irradiation in UVA cabin. The mechanism of triggering is actually unclear. It is supposed that UV radiation, heat, and perspiration are necessary to reveal this affection.
  Photodermatology Photoimmunology and Photomedicine 11/2004; 20(5):235-8. · 1.30 Impact Factor
• Article: [Erythropoietic protoporphyria].

  S Pessel, H Adamski, J Chevrant-Breton
  Annales de Dermatologie et de Vénéréologie 03/2004; 131(2):213-6. · 0.72 Impact Factor
• Article: [Chronic cutaneous ulceration due to Leishmania in an Afghani patient].

  V Cannieux, H Adamski, J-P Gangneux, F Le Gall, L Preney, J Chevrant-Breton
  La Revue de Médecine Interne 11/2003; 24(10):696-7. · 0.61 Impact Factor
• Article: Eruptive angiomatous lesions associated with graft-versus-host disease.

  H Adamski, F Le Gall, L Cartron, C Dauriac, G Lancien, J Wechsler, I Ollivier, S Lachgar, C Dosquet, M C Coudert, J Chevrant-Breton
  British Journal of Dermatology 10/2003; 149(3):667-8. · 3.67 Impact Factor